Former FDA Chief Stephen Hahn Joins Venture Capital Firm Behind Moderna COVID Vaccine
Stephen Hahn, MD, who served as commissioner of the U.S. Food and Drug Administration (FDA) from Dec. 17, 2019 through Jan. 20, 2021, has been hired by Flagship Pioneering Co.—the venture capital firm that launched biotechnology Moderna, Inc., maker of the experimental mRNA-1273 COVID-19 biologic currently being distributed in the United States under an emergency […]
Moderna Expects $18.4 Billion in Sales from Its COVID-19 Vaccine This Year
Moderna, Inc. expects to generate $18.4 billion from sales of its experimental mRNA-1273 COVID-19 vaccine being distributed in the U.S. under an Emergency Use Authorization (EUA) granted by the Food and Drug Administration (FDA). This will be the first time that the U.S. based pharmaceutical company will make a profit since it was established in […]
Pfizer CEO Sells Stock Same Day Positive Results of COVID-19 Vaccine Announced
Story Highlights On Nov. 9, 2020, Pfizer released preliminary Phase 3 clinical trial data indicating that its experimental mRNA COVID-19 vaccine is 90 percent effective, triggering a big surge in stock price. Pfizer CEO Albert Bourla immediately sold 60 percent of his company stock, realizing a gain of $5.6 million in what the company called […]
Only Half of Americans Polled Say They Would Get COVID-19 Vaccine
In a poll conducted for CNN during Oct. 1-4, 2020, the Pennsylvania-based market research firm SSRS found that 51 percent of the 1,205 Americans surveyed said they would try to get a COVID-19 vaccine if it were widely available at a low cost, 45 percent said they would not and four percent had no opinion. Sixty […]
Polls Find Many Americans Do Not Want COVID-19 Vaccine as Soon as It’s Licensed
Story Highlights More adults in the U.S. are expressing doubts about the safety of a newly licensed COVID-19 vaccine that might become available this year. The number of poll respondents planning on getting a new coronavirus vaccine as soon as it is FDA approved has fallen from a reported high of 50 to 60 percent […]
Makers of Experimental COVID-19 Vaccines Lobby EU for Liability Protection
Vaccines Europe, a pharmaceutical industry lobbying group, has issued a memo to its member companies saying it would seek liability protection from the European Union (EU) for corporations manufacturing COVID-19 vaccines. The memo, obtained by the Financial Times, expressed concern about the “inevitable risks” of rushing the development and global marketing of COVID-19 vaccines.1 2 3 […]